Inspire Medical Systems (INSP) Asset Writedowns and Impairment (2023 - 2026)

Inspire Medical Systems has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $548000.0 in Q1 2026.

• Quarterly Asset Writedowns and Impairment rose 7.03% year-over-year to $548000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (up 894.34% YoY) and the FY2025 annual result came in at $2.1 million, changed N/A from the prior year.
• Asset Writedowns and Impairment advanced to $548000.0 in Q1 2026 per INSP's latest filing, from $543000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $4.0 million in Q2 2025 and troughed at -$1.3 million in Q4 2023.
• A 4-year average of $810666.7 and a median of $531000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2025 and 2026: Asset Writedowns and Impairment retreated 1.35% in 2025, then advanced 7.03% in 2026.
• Over 4 years, Asset Writedowns and Impairment stood at -$1.3 million in 2023, then soared by 141.26% to $519000.0 in 2024, then advanced by 4.62% to $543000.0 in 2025, then grew by 0.92% to $548000.0 in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $548000.0, $543000.0, and $4.0 million for Q1 2026, Q4 2025, and Q2 2025 respectively.